DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Sapacitabine is an investigational drug.
There have been 9 clinical trials for Sapacitabine. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2011.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are Cyclacel Pharmaceuticals, Inc., AstraZeneca, and M.D. Anderson Cancer Center.
Recent Clinical Trials for Sapacitabine
|Olaparib + Sapacitabine in BRCA Mutant Breast Cancer||AstraZeneca||Phase 1/Phase 2|
|Olaparib + Sapacitabine in BRCA Mutant Breast Cancer||Cyclacel Pharmaceuticals, Inc.||Phase 1/Phase 2|
|Olaparib + Sapacitabine in BRCA Mutant Breast Cancer||Dana-Farber Cancer Institute||Phase 1/Phase 2|